EUVIMEDEUVIMED entdecken
Crossref

Retrospective evaluation of platelet indices and RAS mutations in patients with colon cancer

Merve Şanlıer, Selim Yalçın

Intercontinental Journal of Internal Medicine · 2023

DOI: 10.51271/icjim-0001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intercontinental Journal of Internal Medicine, 2023. Verfasst von Merve Şanlıer und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Colon cancers are one of the most common cancer types in the world and cause significant mortality. The presence of RAS mutation is also associated with poor prognosis in colon cancers and plays an important role in the choice of treatment. Platelet indices, which have recently been evaluated with an easy-to-reach method, have been discussed as an inflammatory marker in many studies. In this study, it was aimed to investigate the relationship between platelet distribution width (PDW), colon cancer stage and the presence of RAS mutation.

Methods

File records of 132 patients who were followed up with the diagnosis of colon cancer in Kırıkkale University Faculty of Medicine, Department of Internal Medicine and Medical Oncology Department between January 1, 2015 and January 1, 2021 were retrospectively analyzed. Patients with RAS mutations and who did not receive chemotherapy were included in the study. Patients with and without RAS mutation were divided into two groups and their platelet index (especially PDW) values were compared. PDW values were compared according to the stages of the patients. The correlation between stage and PDW was examined.

Results

Of the 132 patients included in the study, 82 (62.1%) were male and 50 (37.9%) were female. Participants; 12 (9.1%) stage 1, 23 (17.4%) stage 2, 29 (22%) stage 3, 68 (51.5%) stage 4 colon cancer patients. There were no RAS mutations in 73 (55.3%)patients, and 59 (44.7%) patients had RAS mutations. There was no significant difference in PDW between the two groups with negative and positive RAS mutations (p=0.826). According to the stages; PDW values were significantly different between the four stages (X2=9.878, p=0.020).

Conclusion

In the study, PDW increased as the stage increased, but there was no significant relationship between RAS mutation and PDW. This was attributed to the fact that as the stage increases, the level of inflammation may be associated with an increase. Larger studies on this subject are needed.

Zitieren

APA

Şanlıer, M., & Yalçın, S. (2023). Retrospective evaluation of platelet indices and RAS mutations in patients with colon cancer. Intercontinental Journal of Internal Medicine. https://doi.org/10.51271/icjim-0001

Vancouver

Şanlıer M, Yalçın S. Retrospective evaluation of platelet indices and RAS mutations in patients with colon cancer. Intercontinental Journal of Internal Medicine. 2023. doi:10.51271/icjim-0001

BibTeX
@article{anler2023,
  author = {Şanlıer, Merve and Yalçın, Selim},
  title = {Retrospective evaluation of platelet indices and RAS mutations in patients with colon cancer},
  journal = {Intercontinental Journal of Internal Medicine},
  year = {2023},
  doi = {10.51271/icjim-0001}
}
Kostenlos starten →